Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 6, 2009, Pages 1017-1021

  Tringali, Giuseppe ^a   Lisi, Lucia ^a   De Simone, Maria Laura ^a   Aubry, Jean Michel ^b   Preziosi, Paolo ^a   Pozzoli, Giacomo ^a   Navarra, Pierluigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b HUG   (Switzerland)

Author keywords

Corticotropin releasing hormone; Hippocampus; Hypothalamus; Olanzapine; Quetiapine; Rat

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; OLANZAPINE; POTASSIUM CHLORIDE; POTASSIUM ION; QUETIAPINE; VERATRIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN REGION; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CULTURE MEDIUM; DRUG EFFICACY; DRUG EXPOSURE; HIPPOCAMPUS; HORMONE INHIBITION; HYPOTHALAMUS; IMMUNOREACTIVITY; INCUBATION TIME; NONHUMAN; RADIOIMMUNOASSAY; RAT;

ANIMALS; BENZODIAZEPINES; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DIBENZOTHIAZEPINES; HIPPOCAMPUS; HYPOTHALAMUS; MALE; RATS; RATS, WISTAR;

EID: 67651100638     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.05.012     Document Type: Article

References (19)

1. Arnt J., and Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18 (1998) 63-101
2. Baldessarini R.J., and Tarazi F.I. Pharmacotherapy of psychosis and mania. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodmans and Gilman's the pharmacological basis of therapeutics. 11th ed. (2006), McGraw-Hill Companies 461-500
3. Belmaker R.H., and Agam G. Major depressive disorder. New Engl J Med 358 (2008) 55-68
4. Chen Y., Brunson K.L., Adelmann G., Bender R.A., Frotscher M., and Baram T.Z. Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 126 (2004) 533-540 2008
5. Costa A., Nappi R.E., Smeraldi A., Bergamaschi M., Navarra P., and Grossman A. Novel regulators of the in vitro release of hypothalamic corticotrophin-releasing hormone two decades after its discovery: a review. Funct Neurol 16 4 Suppl (2001) 205-216
6. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Neuropsychopharmacology 8 (1995) 789-819
7. Fabricio A.S., Tringali G., Pozzoli G., and Navarra P. Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism. Psychopharmacology 178 (2005) 78-82
8. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17 (1996) 187-205
9. Kasckow, J.W., Aguilera, G., Mulchahey, J.J., Sheriff, S., Herman, J.P. In vitro regulation of corticotropin-releasing hormone. Life Sci 2003; 73(6):769-81.
10. Lingamaneni R., and Hemmings Jr. H.C. Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes. Neurosci Lett 276 (1999) 127-130
11. Müller M.B., and Wurst W. Getting closer to affective disorders: the role of CRH receptor systems. Trends Mol Med 10 (2004) 409-415
12. Navarra P., Tsagarakis S., Faria M.S., Rees L.H., Besser G.M., and Grossman A.B. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128 (1991) 37-44
13. Park S.W., Lee S.K., Kim J.M., Kang H.C., Yoon J.S., and Kim Y.H. Quetiapine regulates the stress-induced increase in corticotropin-releasing factor mRNA expression in the rat hypothalamus. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 357-360
14. Philip N.S., Carpenter L.L., Tyrka A.R., and Price L.H. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J Psychiatr Pract 14 1 (2008) 34-44
15. Pozzoli G., Tringali G., Dello Russo C., Vairano M., Preziosi P., and Navarra P. HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase. J Neuroimmunol 118 (2001) 268-276
16. Tezval H., Jahn O., Todorovic C., Sasse A., Eckart K., and Spiess J. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc Natl Acad Sci U S A 101 (2004) 9468-9473
17. Tringali G., Aubry J.M., Moscianese K., Zamori C., Vairano M., Preziosi P., et al. Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. J Psychiatry Neurosci 29 (2004) 459-466
18. 2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus. Psychopharmacology 188 (2006) 386-392
19. Triugali G., Pozzli G., Lisi L., and Navarra P. Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism. Endocrinology 148 (2007) 4711-4715